JOHNSON INVESTMENT COUNSEL INC - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 220 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
JOHNSON INVESTMENT COUNSEL INC ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$618,445
+5.4%
18,6220.0%0.01%
-11.1%
Q3 2022$587,000
+3.7%
18,6220.0%0.01%
+12.5%
Q2 2022$566,000
+17.2%
18,6220.0%0.01%
+33.3%
Q1 2022$483,000
+23.8%
18,622
-2.6%
0.01%
+20.0%
Q4 2021$390,000
+6.0%
19,1220.0%0.01%0.0%
Q3 2021$368,000
-17.5%
19,122
-5.0%
0.01%
-16.7%
Q2 2021$446,000
-15.5%
20,1220.0%0.01%
-25.0%
Q1 2021$528,000
+17.1%
20,122
-16.6%
0.01%0.0%
Q4 2020$451,000
+1.8%
24,122
-7.6%
0.01%0.0%
Q3 2020$443,000
+3.3%
26,097
+41.8%
0.01%
-11.1%
Q2 2020$429,000
+107.2%
18,402
-13.1%
0.01%
+125.0%
Q4 2019$207,000
+9.5%
21,168
+6.3%
0.00%0.0%
Q3 2019$189,000
-19.9%
19,9170.0%0.00%
-20.0%
Q2 2019$236,000
-22.6%
19,917
+14.7%
0.01%
-28.6%
Q1 2019$305,000
+1.3%
17,3690.0%0.01%0.0%
Q4 2018$301,000
+35.6%
17,369
+16.4%
0.01%
+40.0%
Q3 2018$222,000
-6.3%
14,9170.0%0.01%
-16.7%
Q2 2018$237,000
+12.3%
14,9170.0%0.01%
+20.0%
Q1 2018$211,000
-7.5%
14,917
-8.4%
0.01%
-16.7%
Q4 2017$228,000
-1.7%
16,2900.0%0.01%0.0%
Q3 2017$232,000
-9.4%
16,2900.0%0.01%
-14.3%
Q2 2017$256,000
+49.7%
16,290
+31.1%
0.01%
+40.0%
Q1 2017$171,000
-61.7%
12,427
-50.8%
0.01%
-64.3%
Q4 2016$447,000
-9.1%
25,277
-1.0%
0.01%
-12.5%
Q3 2016$492,000
-1.0%
25,5250.0%0.02%0.0%
Q2 2016$497,000
-5.5%
25,5250.0%0.02%
-11.1%
Q1 2016$526,000
-0.9%
25,525
-1.5%
0.02%
-5.3%
Q4 2015$531,000
+21.0%
25,925
+1.0%
0.02%
+18.8%
Q3 2015$439,000
-8.9%
25,677
-0.9%
0.02%0.0%
Q2 2015$482,000
-2.4%
25,9020.0%0.02%
-5.9%
Q1 2015$494,000
+16.0%
25,9020.0%0.02%
+21.4%
Q4 2014$426,000
-14.1%
25,902
-7.7%
0.01%
-17.6%
Q3 2014$496,000
-13.6%
28,052
+0.8%
0.02%
-19.0%
Q2 2014$574,000
-5.3%
27,8270.0%0.02%
-4.5%
Q1 2014$606,000
-19.9%
27,827
-2.5%
0.02%
-21.4%
Q4 2013$757,000
+12.3%
28,5520.0%0.03%
+3.7%
Q3 2013$674,000
+10.7%
28,552
+0.7%
0.03%
+8.0%
Q2 2013$609,00028,3520.02%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q2 2022
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders